Other
Maintenance Therapy
0
Pipeline Programs↗
35
Active Trials↗
10
Companies Involved↗
Maintenance Therapy is an early-stage landscape with 0 programs across 10 companies. The most active players are Bristol-Myers Squibb, Frontier Biotechnologies Inc., Novartis.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
103
clinical trials
Completed32 · 31%
Unknown status28 · 27%
Recruiting18 · 17%
Not yet recruiting11 · 11%
Active, not recruiting6 · 6%
Terminated5 · 5%
Other3 · 3%
Clinical Trials
Trial Activity
103 trials
Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML
Recruiting·IInstitute of Hematology & Blood Diseases Hospital, China·Phase 2·NCT07304232·134 enrolled
Page 1 of 7
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)